[go: up one dir, main page]

PL333412A1 - 1-(3-aminoindazol-5-yl)-3-butyl cyclic urea useful as an inhibitor of hiv protease - Google Patents

1-(3-aminoindazol-5-yl)-3-butyl cyclic urea useful as an inhibitor of hiv protease

Info

Publication number
PL333412A1
PL333412A1 PL97333412A PL33341297A PL333412A1 PL 333412 A1 PL333412 A1 PL 333412A1 PL 97333412 A PL97333412 A PL 97333412A PL 33341297 A PL33341297 A PL 33341297A PL 333412 A1 PL333412 A1 PL 333412A1
Authority
PL
Poland
Prior art keywords
aminoindazol
inhibitor
hiv protease
cyclic urea
butyl cyclic
Prior art date
Application number
PL97333412A
Other languages
English (en)
Inventor
James David Rodgers
Patrick Yuk-Sun Lam
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of PL333412A1 publication Critical patent/PL333412A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL97333412A 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-butyl cyclic urea useful as an inhibitor of hiv protease PL333412A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2974696P 1996-11-08 1996-11-08
US74710396A 1996-11-08 1996-11-08
PCT/US1997/020036 WO1998020009A1 (en) 1996-11-08 1997-11-04 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor

Publications (1)

Publication Number Publication Date
PL333412A1 true PL333412A1 (en) 1999-12-06

Family

ID=26705295

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97333412A PL333412A1 (en) 1996-11-08 1997-11-04 1-(3-aminoindazol-5-yl)-3-butyl cyclic urea useful as an inhibitor of hiv protease

Country Status (19)

Country Link
EP (1) EP0937066A1 (no)
JP (1) JP2001503429A (no)
KR (1) KR20000053123A (no)
CN (1) CN1235601A (no)
AU (1) AU722489B2 (no)
BR (1) BR9712755A (no)
CA (1) CA2270963A1 (no)
CZ (1) CZ157499A3 (no)
EA (1) EA001154B1 (no)
EE (1) EE9900187A (no)
HU (1) HUP9904143A3 (no)
IL (1) IL129726A0 (no)
LV (1) LV12374B (no)
NO (1) NO992229L (no)
NZ (1) NZ335919A (no)
PL (1) PL333412A1 (no)
SI (1) SI9720071A (no)
SK (1) SK59599A3 (no)
WO (1) WO1998020009A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001518094A (ja) * 1997-03-31 2001-10-09 デュポン ファーマシューティカルズ カンパニー Ｈｉｖプロテアーゼ阻害剤として有用なインダゾール−環式尿素
US6194391B1 (en) * 1998-06-24 2001-02-27 Emory University 3′-azido-2′,3′-dideoxyuridine administration to treat HIV and related test protocol
FR2810039B1 (fr) 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
AU2871592A (en) * 1991-10-11 1993-05-03 Du Pont Merck Pharmaceutical Company, The Cyclic ureas and analogues useful as retroviral protease inhibitiors

Also Published As

Publication number Publication date
KR20000053123A (ko) 2000-08-25
EA001154B1 (ru) 2000-10-30
IL129726A0 (en) 2000-02-29
SI9720071A (sl) 1999-12-31
CN1235601A (zh) 1999-11-17
EP0937066A1 (en) 1999-08-25
WO1998020009A1 (en) 1998-05-14
BR9712755A (pt) 1999-10-19
LV12374A (lv) 1999-11-20
CA2270963A1 (en) 1998-05-14
EE9900187A (et) 1999-12-15
JP2001503429A (ja) 2001-03-13
NO992229L (no) 1999-06-07
HUP9904143A2 (hu) 2000-06-28
AU722489B2 (en) 2000-08-03
AU5103398A (en) 1998-05-29
NO992229D0 (no) 1999-05-07
HUP9904143A3 (en) 2002-11-28
NZ335919A (en) 2000-09-29
CZ157499A3 (cs) 1999-11-17
SK59599A3 (en) 1999-12-10
EA199900451A1 (ru) 1999-12-29
LV12374B (en) 2000-04-20

Similar Documents

Publication Publication Date Title
AU6870098A (en) Indazoles of cyclic ureas useful as hiv protease inhibitors
PL313871A1 (en) Inhibitors of hiv protease
PL314838A1 (en) Inhibitors of bp-iv-serine protease
IL128378A0 (en) Inhibitors of cysteine protease
PL334059A1 (en) Ketone benzamides useful as calpain inhibitors
IL131661A0 (en) Protease inhibitors
PL337725A1 (en) Inhibitors of proteases
IL132630A0 (en) Protease inhibitors
PL328665A1 (en) Inhibitors of serinic protease
IL132088A0 (en) Protease inhibitors
EP0923535A4 (en) CYSTEINE PROTEASE INHIBITORS
ZA962133B (en) Cyclic urea HIV protease inhibitors.
AUPM982594A0 (en) HIV protease inhibitors
AU5310096A (en) Cyclic urea hiv protease inhibitors
PL333412A1 (en) 1-(3-aminoindazol-5-yl)-3-butyl cyclic urea useful as an inhibitor of hiv protease
PL342602A1 (en) Method of synthesising inhibitors of hiv protease
EP1015438A4 (en) PROTEASE INHIBITORS
ZA984514B (en) Hiv protease inhibitor
ZA966885B (en) Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors.
EP0975612A4 (en) PROTEASE INHIBITORS
IL132998A0 (en) Vif-derived hiv protease inhibitors
ZA979867B (en) 1-(3-Aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
AU2056397A (en) Hydroxyazepanes as inhibitors of glycosidase and hiv protease
ZA979868B (en) A 1-(3-aminondazol-5-yl)-3-buty-cyclic urea useful as a HIV protease inhibitor
AU2698395A (en) Processes and intermediates for the preparation of cyclic urea hiv protease inhibitors